business development

Verisfield’s business actions are based on extraversion. Humans, as doctors and as patients constitute the core factor of our business plans.

Verisfield is selecting strategic partners based on sincere communications and reciprocity.

In order to enhance its product portfolio, Verisfield is selecting its partners through well known and reputable companies in the pharma field. Verisfield is looking for specialization, experience and mutual trust in its partners. The recent expansion of the collaboration with the Italian company Ibsa for the distribution of two new dermoesthetic product lines in Greece and Cyprus reflects these characteristics. With the same criteria Verisfield is choosing its partners in other countries for the distribution of Verisfield’s products in Cyprus, Azerbaijan, Georgia, Uzbekistan, Albania, Israel, Malaysia and Singapore, Vietnam, Hong Kong, South Africa, Jordan and other MENA countries.
For the production of its products, Verisfield has chosen specialized, GMP contract manufacturers in Greece and in other European countries. All pharmaceutical products are produced using the strictest standards in compliance with the EU pharmaceutical legislation. This ensures the high quality and effectiveness of the products marketed.
For the distribution of its products in Greece, Verisfield has selected a strategic partner with years of experience in storage & distribution of pharmaceutical products. Certified according to international standards (ISO / H.A.C.C.P.), ensures prompt and according to approved storage conditions delivery of the products in all destinations within Greece.